HUP0104544A3 - New pharmaceutical composition and the process for its preparation - Google Patents

New pharmaceutical composition and the process for its preparation

Info

Publication number
HUP0104544A3
HUP0104544A3 HU0104544A HUP0104544A HUP0104544A3 HU P0104544 A3 HUP0104544 A3 HU P0104544A3 HU 0104544 A HU0104544 A HU 0104544A HU P0104544 A HUP0104544 A HU P0104544A HU P0104544 A3 HUP0104544 A3 HU P0104544A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical composition
new pharmaceutical
new
composition
Prior art date
Application number
HU0104544A
Other languages
English (en)
Original Assignee
Reddy S Lab Inc Bridgewater Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy S Lab Inc Bridgewater Dr filed Critical Reddy S Lab Inc Bridgewater Dr
Publication of HUP0104544A2 publication Critical patent/HUP0104544A2/hu
Publication of HUP0104544A3 publication Critical patent/HUP0104544A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0104544A 1998-12-01 1999-11-29 New pharmaceutical composition and the process for its preparation HUP0104544A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199801580 1998-12-01

Publications (2)

Publication Number Publication Date
HUP0104544A2 HUP0104544A2 (en) 2002-08-28
HUP0104544A3 true HUP0104544A3 (en) 2003-12-29

Family

ID=8106261

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0104544A HUP0104544A3 (en) 1998-12-01 1999-11-29 New pharmaceutical composition and the process for its preparation

Country Status (21)

Country Link
US (1) US7439248B1 (hu)
EP (1) EP1135127B1 (hu)
JP (2) JP5524435B2 (hu)
KR (1) KR100690311B1 (hu)
CN (1) CN1158075C (hu)
AT (1) ATE316376T1 (hu)
AU (1) AU776299B2 (hu)
BR (1) BR9915835A (hu)
CA (1) CA2352430C (hu)
CZ (1) CZ300543B6 (hu)
DE (1) DE69929635T2 (hu)
ES (1) ES2257886T3 (hu)
HU (1) HUP0104544A3 (hu)
IL (3) IL143299A0 (hu)
NO (1) NO329909B1 (hu)
PL (1) PL197077B1 (hu)
RU (1) RU2233659C2 (hu)
TW (1) TWI235657B (hu)
UA (1) UA75569C2 (hu)
WO (1) WO2000032191A1 (hu)
ZA (1) ZA200104261B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL197077B1 (pl) * 1998-12-01 2008-02-29 Reddys Lab Inc Dr Kompozycja farmaceutyczna zawierająca 5-[[4-[3-metylo-4-okso-3,4-dihydro-2-chinazolinylo]metoksy]fenylometylo]-tiazolidyno-2,4-dion lub jego sól dopuszczalną do stosowania w farmacji i sposób jej wytwarzania
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
JP2004506609A (ja) 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
CA2469940A1 (en) * 2001-12-19 2003-06-26 Takeda Chemical Industries, Ltd. Solid compositions comprising compounds unstable to oxygen and method for stabilizing them
WO2006002255A2 (en) * 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. A pharmaceutical formulation of balaglitazone
CL2008000596A1 (es) * 2007-03-01 2008-09-05 Glaxo Group Ltd Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280997A (en) * 1978-12-08 1981-07-28 Johannes Van Leverink Extrusion process for the preparation of anhydrous stable lactose
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
CA2019324C (en) * 1989-07-10 1996-08-20 Robert L. Jerzewski Fosinopril tablet formulations
IT1238072B (it) * 1990-01-19 1993-07-03 Sclavo Spa Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
SK121193A3 (en) * 1991-04-04 1994-07-06 Procter & Gamble Chewable antacid compositions
SK117793A3 (en) * 1991-04-29 1994-05-11 Merck & Co Inc Optimized tablet formulation
TW268952B (hu) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
AU7719894A (en) * 1993-09-03 1995-03-22 Smithkline Beecham Corporation Stabilized tablet formulation
US5532256A (en) 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
WO1996018386A1 (en) * 1994-12-14 1996-06-20 Enbalt Trading Limited Pharmaceutical tablet formulations for direct compression
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
JPH09249561A (ja) * 1996-03-15 1997-09-22 Teikoku Chem Ind Corp Ltd 医薬組成物
HU222109B1 (hu) * 1996-09-10 2003-04-28 EGIS Gyógyszergyár Rt. Captopriltartalmú tabletták és eljárás ezek előállítására
DK0958296T3 (da) * 1996-12-31 2003-08-18 Reddys Lab Ltd Dr Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
JP2002510283A (ja) 1997-12-02 2002-04-02 ドクター・レディーズ・リサーチ・ファウンデーション 抗糖尿病性、低脂質性及び抗高血圧性を有する置換チアゾリンジオンとオキサゾリジンジオン
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
PL197077B1 (pl) * 1998-12-01 2008-02-29 Reddys Lab Inc Dr Kompozycja farmaceutyczna zawierająca 5-[[4-[3-metylo-4-okso-3,4-dihydro-2-chinazolinylo]metoksy]fenylometylo]-tiazolidyno-2,4-dion lub jego sól dopuszczalną do stosowania w farmacji i sposób jej wytwarzania
JP2004506609A (ja) * 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
WO2006002255A2 (en) 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. A pharmaceutical formulation of balaglitazone

Also Published As

Publication number Publication date
IL179865A0 (en) 2007-05-15
KR100690311B1 (ko) 2007-03-09
CA2352430C (en) 2008-11-18
AU1376200A (en) 2000-06-19
EP1135127A1 (en) 2001-09-26
EP1135127B1 (en) 2006-01-25
CN1356901A (zh) 2002-07-03
NO20012673L (no) 2001-05-31
CN1158075C (zh) 2004-07-21
CZ300543B6 (cs) 2009-06-10
ZA200104261B (en) 2002-05-24
PL348601A1 (en) 2002-06-03
CA2352430A1 (en) 2000-06-08
IL143299A0 (en) 2002-04-21
BR9915835A (pt) 2001-08-21
ATE316376T1 (de) 2006-02-15
WO2000032191A1 (en) 2000-06-08
IL179865A (en) 2009-12-24
CZ20011832A3 (cs) 2001-10-17
HUP0104544A2 (en) 2002-08-28
UA75569C2 (en) 2006-05-15
TWI235657B (en) 2005-07-11
DE69929635D1 (de) 2006-04-13
RU2233659C2 (ru) 2004-08-10
JP5524435B2 (ja) 2014-06-18
DE69929635T2 (de) 2006-09-21
IL143299A (en) 2006-12-31
NO329909B1 (no) 2011-01-24
KR20010099827A (ko) 2001-11-09
US7439248B1 (en) 2008-10-21
JP2012144560A (ja) 2012-08-02
ES2257886T3 (es) 2006-08-01
PL197077B1 (pl) 2008-02-29
NO20012673D0 (no) 2001-05-31
AU776299B2 (en) 2004-09-02
JP2002531404A (ja) 2002-09-24

Similar Documents

Publication Publication Date Title
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
HUP0004024A3 (en) Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof
HUP0001539A3 (en) 2-(1-iminoethylamino)ethyl-homocysteine, process for its preparation and pharmaceutical compositions containing the same
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP0103511A3 (en) Oxazole compounds and pharmaceutical compositions containing them and process for preparation the compounds
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
HUP0102711A3 (en) Epothilone derivatives and pharmaceutical compositions containing them and process for preparation the same
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
HUP9700328A3 (en) Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
PT1466615E (pt) Composição farmacêutica
HUP0000426A3 (en) Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
IL137494A0 (en) Polypeptide compounds, process for the preparation thereof and pharmaceutical compositions containing the same
PL343769A1 (en) Pharmaceutical composition
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HK1039122A1 (zh) 取代的6-苄基-4-氧代嘧啶，其製備方法以及含該化合物的藥物組合物
GB9818591D0 (en) Pharmaceutical composition
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
HUP0101256A3 (en) Pharmaceutical composition having antitumor activity and process for the preparation thereof
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: DR. REDDY'S LABORATORIES, INC., US

Free format text: FORMER OWNER(S): NOVO NORDISK A/S, DK; DR. REDDY'S RESEARCH FOUNDATION, IN

Owner name: DR. REDDY'S LABORATORIES LIMITED, IN

Free format text: FORMER OWNER(S): NOVO NORDISK A/S, DK; DR. REDDY'S RESEARCH FOUNDATION, IN

FD9A Lapse of provisional protection due to non-payment of fees